CCK and pancreatic neoplasm: CCK-BRs are present on activated pancreatic stellate cells or fibroblasts, and interruption of this signaling pathway decreases the genes implicated in epithelial to mesenchymal transition, invasion, and metastases in pancreatic cancer.